Search filters

List of works by Hiroshi Ueoka

A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) Trial 0

A case of pneumonitis induced by CDDP and 5-FU

scientific article published in May 2005

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer

scientific article

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer

scientific article

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer

scientific article

A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer

scientific article

A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0801.

scientific article

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401.

scientific article published on 18 February 2011

A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.

scientific article published on 8 November 2014

A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102.

scientific article

A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer

scientific article

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors

scientific article

A survey of Japanese thoracic oncologists' perception of diagnostic and treatment strategies for EGFR mutant or EML4-ALK fusion non-small cell lung cancer

scientific article published in December 2014

Aberrant promoter hypermethylation in serum DNA from patients with silicosis

scientific article published on 16 July 2008

Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion

scientific article published in May 2007

Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer

scientific article

An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer

scientific article published in October 2004

Association between poor performance status and risk for toxicity during erlotinib monotherapy in Japanese patients with non-small cell lung cancer: Okayama Lung Cancer Study Group experience

scientific article published on 22 April 2010

Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer

scientific article published on 15 May 2008

Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007

article

Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

scientific article published in March 2002

Cisplatin down-regulates topoisomerase I activity in lung cancer cell lines.

scientific article published on November 2004

Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients

scientific article published on 4 May 2004

Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancer

scientific article published in October 2006

Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer: experience at a single institution

scientific article

Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer

scientific article

Comparison of chemosensitivity tests: clonogenic assay versus MTT assay

scientific article published in June 2002

Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience

scientific article published in February 2010

Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma

scientific article published on 5 November 2004

Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancer

scientific article published in October 2002

Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of cisplatin accumulation and topoisomerase I activity

scientific article published on July 2005

Dramatic effect of ZD1839 ('Iressa') in a patient with advanced non-small-cell lung cancer and poor performance status

scientific article published in April 2003

Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer

scientific article published in November 2004

Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell line.

scientific article published on November 2004

Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study.

scientific article published in January 2003

Gefitinib ('Iressa', ZD1839) may restore chemosensitivity in NSCLC patients?

scientific article published in January 2005

Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation.

scientific article published on February 2007

Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: results from a prospective feasibility study

scientific article

Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.

scientific article published in February 2005

Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer

scientific article published in May 2008

Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells

scientific article published on 8 August 2003

Influence of altering administration sequence of docetaxel, gemcitabine and cisplatin in patients with advanced non-small cell lung cancer

scientific article

Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group

scientific article

Long-term effect of gefitinib (ZD1839) on squamous cell carcinoma of the lung

scientific article published in January 2004

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer

scientific article

Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.

scientific article

Phase I study of docetaxel and irinotecan in patients with advanced non-small-cell lung cancer

scientific article

Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.

scientific article

Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer

scientific article

Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.

scientific article published in March 2015

Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.

scientific article published on 7 June 2010

Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.

scientific article published in May 2003

Recent improvement in lung cancer screening: a comparison of the results carried out in two different time periods

scientific article published in June 2006

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

scientific article published on March 2007

Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine

scientific article

Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases

scientific article published on August 2002

Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials

scientific article

Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience

scientific article

Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer

scientific article

Severe interstitial pneumonia induced by paclitaxel in a patient with adenocarcinoma of the lung.

scientific article published on October 2006

Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group experience

scientific article

Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin

scientific article published on 23 June 2005

Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer

scientific article published in September 2005

Tandem high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation for recurrent soft tissue sarcoma.

scientific article published in September 2002

The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells.

scientific article published on April 2006

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

scientific article published in February 2005

Thrombocytosis as a useful prognostic indicator in patients with lung cancer

scientific article published in March 2004

Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small cell lung cancer: a phase I/II trial.

scientific article published on January 2007

Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer

scientific article published on February 2010

Paulina is supported by:

About Paulina

Help